colon is the longest part of the large intestine and the rectum is the last few
inches of the large intestine before the anus. Polyps which are benign lumps
may form on the inner wall of the colon and rectum. However, certain type of
polyps may develop into cancer and should be removed if they are detected. This
cancer is known as the cancer of the colon or rectum.
Cancer is the third most common cancer in the world amongst men and second most
common cancer amongst women. In 2018, there were 1.8 million new cases
diagnosed. Both men and women above the age of 50 years are encouraged to do
yearly Colorectal Cancer screening which can aid in the early detection and
treatment of polyps.
is a non-invasive blood test for the early detection of colorectal cancer and
precancerous lesions which detects and quantifies Circulating Tumour Cells
are cells that are shed by the primary tumour into the bloodstream. Unlike
Faecal Immunochemical Test which detects small amounts of blood in the faeces, CRCProtect™
detects as minute as 1 CTC per 10 billion blood cells to come up with the risk
score of an individual having colorectal cancer.
is a non-invasive blood test, individuals may discuss with their doctors to
have CRCProtect™ incorporated into their regular health screening. CRCProtect™ eliminates the need for bowel
preparation associated with a screening colonoscopy and compliance issues
associated with faecal immunochemical testing.